Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients.

Orally administered by statin-intolerant patients, bempedoic acid is a novel drug used to treat high LDL cholesterol conditions indicative of cardiovascular disease.

• Stocks in Focus: ONGC, Reliance Power, Tata Power and Others
• Stocks Under F&O Ban: Hindustan Copper, PVR Inox, RBL Bank, and Others
• GMR Airports Gears up for Next Phase of Growth; Launches New Operations Centre 
• Sai Life Sciences Ltd IPO GMP & Lot Size Details : Worth Investing Or Not?
• BEML Shares Rally 4% on Securing a Rs 136 Crore Order 

“An estimated 112 million Indian adults have high LDL cholesterol levels, and large numbers of dyslipidemia patients receiving statin therapy continue to experience uncontrolled dyslipidemia for these patients, bebedoic acid is a silver lining,” Director Sandeep Jain said.